These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34376791)

  • 1. Serum erythroferrone levels during the first month of life in premature infants.
    Lenhartová N; Ochiai M; Sawano T; Yasuoka K; Fujiyoshi J; Inoue H; Ohga S
    J Perinatol; 2022 Jan; 42(1):97-102. PubMed ID: 34376791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?
    Bahr TM; Ward DM; Jia X; Ohls RK; German KR; Christensen RD
    Blood Cells Mol Dis; 2021 May; 88():102536. PubMed ID: 33450539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal range and predictors of serum erythroferrone in infants.
    Bäckström F; Chmielewska A; Domellöf M; Berglund SK
    Pediatr Res; 2023 Sep; 94(3):965-970. PubMed ID: 37069224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples.
    Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
    J Nutr; 2021 Sep; 151(9):2590-2600. PubMed ID: 34236433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
    Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
    Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients.
    Youssry I; Samy RM; AbdelMohsen M; Salama NM
    Pediatr Res; 2024 Mar; 95(4):1095-1100. PubMed ID: 37464096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroferrone and hepcidin levels in children with iron deficiency anemia.
    Dulkadir R; Turna Saltoğlu G; Güneş A
    BMC Pediatr; 2024 Apr; 24(1):240. PubMed ID: 38575873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.
    Srole DN; Ganz T
    J Cell Physiol; 2021 Jul; 236(7):4888-4901. PubMed ID: 33372284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
    Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
    PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents.
    Inomata S; Anan A; Yamauchi E; Yamauchi R; Kunimoto H; Takata K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Shakado S; Sohda T; Sakisaka S
    Intern Med; 2019 Oct; 58(20):2915-2922. PubMed ID: 31243222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia, Hepcidin, and Vitamin D in Healthy Preterm Infants: A Pilot Study.
    Koren Y; Lubetzky R; Mandel D; Ovental A; Deutsch V; Hadanny A; Moran-Lev H
    Am J Perinatol; 2023 Apr; 40(5):508-512. PubMed ID: 33940646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.
    Breenfeldt Andersen A; Bonne TC; Bejder J; Jung G; Ganz T; Nemeth E; Olsen NV; Huertas JR; Nordsborg NB
    Am J Physiol Regul Integr Comp Physiol; 2021 Aug; 321(2):R152-R161. PubMed ID: 34160288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.
    Miura S; Kobune M; Horiguchi H; Kikuchi S; Iyama S; Murase K; Goto A; Ikeda H; Takada K; Miyanishi K; Kato J
    Blood Cells Mol Dis; 2019 Sep; 78():1-8. PubMed ID: 31082798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental Erythroferrone and Erythropoietin mRNA Expression is not Associated with Maternal or Neonatal Iron Status in Adolescents Carrying Singletons and Adult Women Carrying Multiples.
    Delaney KM; Barad A; Castillo LF; Hasund CM; Guillet R; Pressman EK; Katzman PJ; Ganz T; Nemeth E; O'Brien KO
    J Nutr; 2023 Jul; 153(7):1950-1958. PubMed ID: 37253412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin-25/erythroferrone ratio predicts improvement of anaemia in haemodialysis patients treated with ferric citrate hydrate.
    Hara M; Nakamura Y; Suzuki H; Asao R; Nakamura M; Nishida K; Kenmotsu S; Inagaki M; Tsuji M; Kiuchi Y; Ohsawa I; Goto Y; Gotoh H
    Nephrology (Carlton); 2019 Aug; 24(8):819-826. PubMed ID: 30239062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Serum Hepcidin Levels in Patients with Ulcerative Colitis - Implications for Treatment of Co-existent Iron-Deficiency Anemia.
    Ramasamy J; Jagadish C; Sukumaran A; Varghese J; Mani T; Joseph AJ; Simon EG; Jacob M
    Inflammation; 2023 Dec; 46(6):2209-2222. PubMed ID: 37486527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of erythroferrone structural domains relevant to its iron-regulatory function.
    Srole DN; Jung G; Waring AJ; Nemeth E; Ganz T
    J Biol Chem; 2023 Dec; 299(12):105374. PubMed ID: 37866631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.
    Arezes J; Foy N; McHugh K; Quinkert D; Benard S; Sawant A; Frost JN; Armitage AE; Pasricha SR; Lim PJ; Tam MS; Lavallie E; Pittman DD; Cunningham O; Lambert M; Murphy JE; Draper SJ; Jasuja R; Drakesmith H
    Blood; 2020 Feb; 135(8):547-557. PubMed ID: 31899794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.
    El-Gamal RAE; Abdel-Messih IY; Habashy DM; Zaiema SEG; Pessar SA
    Ann Hematol; 2020 Jan; 99(1):31-39. PubMed ID: 31834456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent.
    Tomczyk M; Kortas J; Flis D; Kaczorowska-Hac B; Grzybkowska A; Borkowska A; Lewicka E; Dabrowska-Kugacka A; Antosiewicz J
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32316587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.